Market Overview

Benzinga's Top Upgrades, Downgrades For September 26, 2019

Share:

Upgrades

  • For AbbVie Inc (NYSE: ABBV), Citigroup upgraded the stock from Neutral to Buy. For the second quarter, AbbVie had an EPS of $2.26, compared to year-ago quarter EPS of $2.00. The current market cap for AbbVie is at $107.8 billion. The stock has a 52-week-high of $96.60 and a 52-week-low of $62.66. AbbVie's stock last closed at $72.09 per share.
  • For Advanced Energy Industries Inc (NASDAQ: AEIS), DA Davidson upgraded the stock from Neutral to Buy. In the second quarter, Advanced Energy Indus showed an EPS of $0.45, compared to $1.25 from the year-ago quarter. The total market value of Advanced Energy Indus's outstanding shares is at $2.2 billion. The stock has a 52-week-high of $60.76 and a 52-week-low of $38.74. Advanced Energy Indus's stock last closed at $58.97 per share.
  • ScotiaBank upgraded the stock for Banco Macro SA (NYSE: BMA) from Underperform to Sector Perform. Banco Macro earned $2.59 in the second quarter, compared to $1.61 in the year-ago quarter. Banco Macro's market cap stands at $1.7 billion. The stock has a 52-week-high of $77.31 and a 52-week-low of $21.41. Banco Macro's stock last closed at $24.49 per share.
  • Bank of America changed the rating for Bruker Corp (NASDAQ: BRKR) from Neutral to Buy. For the second quarter, Bruker had an EPS of $0.33, compared to year-ago quarter EPS of $0.25. Bruker's market cap stands at $6.5 billion. The stock has a 52-week-high of $51.41 and a 52-week-low of $26.10. Bruker's stock last closed at $43.27 per share.
  • Goldman Sachs changed the rating for Cenovus Energy Inc (NYSE: CVE) from Neutral to Buy. For the second quarter, Cenovus Energy had an EPS of $0.17, compared to year-ago quarter EPS of ($0.19). The current market cap for Cenovus Energy is at $11.9 billion. The stock has a 52-week-high of $10.82 and a 52-week-low of $6.15. Cenovus Energy's stock last closed at $9.71 per share.
  • UBS changed the rating for EQM Midstream Partners LP (NYSE: EQM) from Neutral to Buy. EQM Midstream Partners earned $1.01 in the second quarter, compared to $1.09 in the year-ago quarter. The total market value of EQM Midstream Partners's outstanding shares is at $6.4 billion. The stock has a 52-week-high of $55.33 and a 52-week-low of $28.44. EQM Midstream Partners's stock last closed at $31.54 per share.
  • For Equitrans Midstream Corp (NYSE: ETRN), UBS upgraded the stock from Neutral to Buy. The total market value of Equitrans Midstream's outstanding shares is at $3.5 billion. The stock has a 52-week-high of $23.47 and a 52-week-low of $12.31. Equitrans Midstream's stock last closed at $14.13 per share.
  • ScotiaBank upgraded the stock for Grupo Financiero Galicia SA (NASDAQ: GGAL) from Sector Underperform to Sector Perform. For the second quarter, Grupo Financiero Galicia had an EPS of $0.18, compared to year-ago quarter EPS of $0.06. Grupo Financiero Galicia's market cap stands at $1.9 billion. The stock has a 52-week-high of $39.22 and a 52-week-low of $9.53. Grupo Financiero Galicia's stock last closed at $12.36 per share.
  • For Hologic Inc (NASDAQ: HOLX), Bank of America upgraded the stock from Neutral to Buy. In the third quarter, Hologic showed an EPS of $0.63, compared to $0.58 from the year-ago quarter. The total market value of Hologic's outstanding shares is at $13.3 billion. The stock has a 52-week-high of $52.19 and a 52-week-low of $37.47. Hologic's stock last closed at $50.00 per share.
  • JP Morgan changed the rating for Micro Focus International PLC (NYSE: MFGP) from Underweight to Neutral. The stock has a 52-week-high of $32.93 and a 52-week-low of $12.50. Micro Focus Intl's stock last closed at $13.73 per share.
  • For PerkinElmer Inc (NYSE: PKI), Bank of America upgraded the stock from Neutral to Buy. In the second quarter, PerkinElmer showed an EPS of $1.00, compared to $0.91 from the year-ago quarter. The current market cap for PerkinElmer is at $9.4 billion. The stock has a 52-week-high of $103.00 and a 52-week-low of $71.83. PerkinElmer's stock last closed at $84.48 per share.
  • For Personalis Inc (NASDAQ: PSNL), Bank of America upgraded the stock from Neutral to Buy. In the second quarter, Personalis earned ($0.89). Personalis's market cap stands at $523.2 million. The stock has a 52-week-high of $31.88 and a 52-week-low of $14.25. Personalis's stock last closed at $16.41 per share.
  • BMO Capital changed the rating for Boston Beer Co Inc (NYSE: SAM) from Market Perform to Outperform. In the second quarter, Boston Beer Co showed an EPS of $2.34, compared to $1.98 from the year-ago quarter. Boston Beer Co's market cap stands at $4.1 billion. The stock has a 52-week-high of $444.64 and a 52-week-low of $230.93. Boston Beer Co's stock last closed at $348.75 per share.
  • Sandler O'Neill changed the rating for Sandy Spring Bancorp Inc (NASDAQ: SASR) from Hold to Buy. In the second quarter, Sandy Spring Bancorp showed an EPS of $0.79, compared to $0.73 from the year-ago quarter. The current market cap for Sandy Spring Bancorp is at $168.4 million. The stock has a 52-week-high of $39.92 and a 52-week-low of $29.83. Sandy Spring Bancorp's stock last closed at $33.52 per share.
  • For Square Inc (NYSE: SQ), Wells Fargo upgraded the stock from Market Perform to Outperform. In the second quarter, Square showed an EPS of $0.21, compared to $0.13 from the year-ago quarter. The total market value of Square's outstanding shares is at $24.5 billion. The stock has a 52-week-high of $101.15 and a 52-week-low of $49.82. Square's stock last closed at $58.53 per share.
  • For The Trade Desk Inc (NASDAQ: TTD), Nomura upgraded the stock from Reduce to Neutral. In the second quarter, Trade Desk showed an EPS of $0.95, compared to $0.60 from the year-ago quarter. Trade Desk's market cap stands at $8.6 billion. The stock has a 52-week-high of $289.51 and a 52-week-low of $102.35. Trade Desk's stock last closed at $194.58 per share.
  • For Veeva Systems Inc (NYSE: VEEV), Raymond James upgraded the stock from Market Perform to Outperform. Veeva Systems earned $0.55 in the second quarter, compared to $0.39 in the year-ago quarter. The current market cap for Veeva Systems is at $22.3 billion. The stock has a 52-week-high of $176.90 and a 52-week-low of $79.26. Veeva Systems's stock last closed at $155.40 per share.
  • JP Morgan upgraded the stock for Whirlpool Corp (NYSE: WHR) from Neutral to Overweight. Whirlpool earned $4.01 in the second quarter, compared to $3.20 in the year-ago quarter. The current market cap for Whirlpool is at $9.4 billion. The stock has a 52-week-high of $153.22 and a 52-week-low of $99.40. Whirlpool's stock last closed at $150.46 per share.

 

Downgrades

  • For Beacon Roofing Supply Inc (NASDAQ: BECN), JP Morgan downgraded the stock from Neutral to Underweight. Beacon Roofing Supply earned $1.12 in the third quarter, compared to $1.18 in the year-ago quarter. Beacon Roofing Supply's market cap stands at $2.2 billion. The stock has a 52-week-high of $40.00 and a 52-week-low of $24.96. Beacon Roofing Supply's stock last closed at $34.00 per share.
  • For Enanta Pharmaceuticals Inc (NASDAQ: ENTA), JP Morgan downgraded the stock from Neutral to Underweight. In the third quarter, Enanta Pharmaceuticals showed an EPS of $0.33, compared to $0.97 from the year-ago quarter. Enanta Pharmaceuticals's market cap stands at $1.4 billion. The stock has a 52-week-high of $106.80 and a 52-week-low of $63.37. Enanta Pharmaceuticals's stock last closed at $71.28 per share.
  • William Blair changed the rating for HD Supply Holdings Inc (NASDAQ: HDS) from Outperform to Market Perform. In the second quarter, HD Supply Holdings showed an EPS of $1.08, compared to $0.99 from the year-ago quarter. The current market cap for HD Supply Holdings is at $6.2 billion. The stock has a 52-week-high of $47.13 and a 52-week-low of $35.35. HD Supply Holdings's stock last closed at $39.24 per share.
  • Barclays downgraded the stock for HD Supply Holdings Inc (NASDAQ: HDS) from Overweight to Equal-Weight. For the second quarter, HD Supply Holdings had an EPS of $1.08, compared to year-ago quarter EPS of $0.99. HD Supply Holdings's market cap stands at $6.2 billion. The stock has a 52-week-high of $47.13 and a 52-week-low of $35.35. HD Supply Holdings's stock last closed at $39.24 per share.
  • Bank of America downgraded the stock for Herc Holdings Inc (NYSE: HRI) from Buy to Neutral. For the second quarter, Herc Holdings had an EPS of $0.33, compared to year-ago quarter EPS of ($0.01). The total market value of Herc Holdings's outstanding shares is at $1.3 billion. The stock has a 52-week-high of $51.90 and a 52-week-low of $24.16. Herc Holdings's stock last closed at $48.84 per share.
  • For Imperial Oil Ltd (AMEX: IMO), Goldman Sachs downgraded the stock from Buy to Neutral. Imperial Oil earned $0.74 in the third quarter, compared to $0.34 in the year-ago quarter. The total market value of Imperial Oil's outstanding shares is at $20.4 billion. The stock has a 52-week-high of $34.56 and a 52-week-low of $23.71. Imperial Oil's stock last closed at $26.71 per share.
  • For Macerich Co (NYSE: MAC), BMO Capital downgraded the stock from Outperform to Market Perform. In the second quarter, Macerich showed an EPS of $0.88, compared to $0.96 from the year-ago quarter. The total market value of Macerich's outstanding shares is at $4.4 billion. The stock has a 52-week-high of $55.90 and a 52-week-low of $27.54. Macerich's stock last closed at $32.06 per share.
  • Bank of America downgraded the stock for Myriad Genetics Inc (NASDAQ: MYGN) from Neutral to Underperform. In the fourth quarter, Myriad Genetics showed an EPS of $0.41, compared to $0.38 from the year-ago quarter. Myriad Genetics's market cap stands at $2.2 billion. The stock has a 52-week-high of $48.77 and a 52-week-low of $22.04. Myriad Genetics's stock last closed at $29.93 per share.
  • For NIO Inc (NYSE: NIO), Morgan Stanley downgraded the stock from Overweight to Equal-Weight. In the second quarter, NIO earned ($0.45). The current market cap for NIO is at $3.6 billion. The stock has a 52-week-high of $10.64 and a 52-week-low of $1.97. NIO's stock last closed at $2.05 per share.
  • UBS downgraded the stock for Northern Trust Corp (NASDAQ: NTRS) from Buy to Neutral. In the second quarter, Northern Trust showed an EPS of $1.75, compared to $1.68 from the year-ago quarter. Northern Trust's market cap stands at $20.2 billion. The stock has a 52-week-high of $107.24 and a 52-week-low of $75.96. Northern Trust's stock last closed at $95.31 per share.
  • For The Timken Co (NYSE: TKR), Bank of America downgraded the stock from Neutral to Underperform. Timken earned $1.27 in the second quarter, compared to $1.11 in the year-ago quarter. The current market cap for Timken is at $3.2 billion. The stock has a 52-week-high of $52.38 and a 52-week-low of $33.98. Timken's stock last closed at $43.78 per share.

 

Initiations

  • With a rating of Buy, Bank of America initiated coverage on Aaron's Inc (NYSE: AAN). The price target is set at $75.00 for Aaron's. Aaron's earned $0.93 in the second quarter, compared to $0.84 in the year-ago quarter. The total market value of Aaron's's outstanding shares is at $4.1 billion. The stock has a 52-week-high of $68.44 and a 52-week-low of $39.28. Aaron's's stock last closed at $61.63 per share.
  • DA Davidson initiated coverage on American Finance Trust Inc (NASDAQ: AFIN) with a Neutral rating. The price target for American Finance Trust is set at $15.00. Interestingly, in the second quarter, American Finance Trust's EPS was $0.28. American Finance Trust's market cap stands at $1.4 billion. The stock has a 52-week-high of $16.89 and a 52-week-low of $9.36. American Finance Trust's stock last closed at $13.98 per share.
  • William Blair initiated coverage on Alexion Pharmaceuticals Inc (NASDAQ: ALXN) with an Outperform rating. The price target for Alexion Pharmaceuticals is set at $146.00. In the second quarter, Alexion Pharmaceuticals showed an EPS of $2.64, compared to $2.07 from the year-ago quarter. Alexion Pharmaceuticals's market cap stands at $22.4 billion. The stock has a 52-week-high of $141.86 and a 52-week-low of $92.56. Alexion Pharmaceuticals's stock last closed at $100.40 per share.
  • Bank of America initiated coverage on Celanese Corp (NYSE: CE) with an Underperform rating. The price target for Celanese is set at $110.00. For the second quarter, Celanese had an EPS of $2.38, compared to year-ago quarter EPS of $2.90. The current market cap for Celanese is at $15.0 billion. The stock has a 52-week-high of $127.15 and a 52-week-low of $82.91. Celanese's stock last closed at $122.26 per share.
  • With a rating of Neutral, Baird initiated coverage on CrowdStrike Holdings Inc (NASDAQ: CRWD). The price target is set at $75.00 for CrowdStrike Holdings. CrowdStrike Holdings earned ($0.18) in the second quarter. CrowdStrike Holdings's market cap stands at $14.1 billion. The stock has a 52-week-high of $101.88 and a 52-week-low of $56.00. CrowdStrike Holdings's stock last closed at $62.02 per share.
  • With a rating of Neutral, JP Morgan initiated coverage on Carvana Co (NYSE: CVNA). The price target is set at $75.00 for Carvana. For the second quarter, Carvana had an EPS of ($0.40), compared to year-ago quarter EPS of ($0.37). Carvana's market cap stands at $10.6 billion. The stock has a 52-week-high of $85.07 and a 52-week-low of $28.44. Carvana's stock last closed at $70.51 per share.
  • With a rating of Neutral, Wedbush initiated coverage on Denali Therapeutics Inc (NASDAQ: DNLI). The price target is set at $19.00 for Denali Therapeutics. In the second quarter, Denali Therapeutics showed an EPS of ($0.61), compared to ($0.59) from the year-ago quarter. The current market cap for Denali Therapeutics is at $1.6 billion. The stock has a 52-week-high of $28.86 and a 52-week-low of $13.78. Denali Therapeutics's stock last closed at $17.32 per share.
  • Bank of America initiated coverage on Eastman Chemical Co (NYSE: EMN) with a Buy rating. The price target for Eastman Chemical is set at $84.00. For the second quarter, Eastman Chemical had an EPS of $1.99, compared to year-ago quarter EPS of $2.22. Eastman Chemical's market cap stands at $9.7 billion. The stock has a 52-week-high of $99.43 and a 52-week-low of $61.22. Eastman Chemical's stock last closed at $72.67 per share.
  • Macquarie initiated coverage on Everi Holdings Inc (NYSE: EVRI) with an Outperform rating. The price target for Everi Holdings is set at $12.00. For the second quarter, Everi Holdings had an EPS of $0.08, compared to year-ago quarter EPS of $0.04. The total market value of Everi Holdings's outstanding shares is at $658.2 million. The stock has a 52-week-high of $12.56 and a 52-week-low of $4.76. Everi Holdings's stock last closed at $9.26 per share.
  • Oppenheimer initiated coverage on Exact Sciences Corp (NASDAQ: EXAS) with an Outperform rating. The price target for Exact Sciences is set at $130.00. In the second quarter, Exact Sciences showed an EPS of ($0.30), compared to ($0.30) from the year-ago quarter. The current market cap for Exact Sciences is at $12.8 billion. The stock has a 52-week-high of $123.99 and a 52-week-low of $53.06. Exact Sciences's stock last closed at $97.28 per share.
  • With a rating of Buy, Guggenheim initiated coverage on Five9 Inc (NASDAQ: FIVN). The price target is set at $70.00 for Five9. In the second quarter, Five9 showed an EPS of $0.20, compared to $0.11 from the year-ago quarter. The current market cap for Five9 is at $3.3 billion. The stock has a 52-week-high of $65.45 and a 52-week-low of $34.66. Five9's stock last closed at $55.98 per share.
  • For Global Net Lease Inc (NYSE: GNL), DA Davidson initiated coverage, by setting the current rating at Neutral. Global Net Lease earned $0.45 in the second quarter, compared to $0.61 in the year-ago quarter. Global Net Lease's market cap stands at $1.6 billion. The stock has a 52-week-high of $21.93 and a 52-week-low of $16.95. Global Net Lease's stock last closed at $19.45 per share.
  • Barclays initiated coverage on Helmerich & Payne Inc (NYSE: HP) with an Overweight rating. The price target for Helmerich & Payne is set at $48.00. For the third quarter, Helmerich & Payne had an EPS of $0.41, compared to year-ago quarter EPS of ($0.01). Helmerich & Payne's market cap stands at $4.4 billion. The stock has a 52-week-high of $73.74 and a 52-week-low of $36.06. Helmerich & Payne's stock last closed at $41.06 per share.
  • With a rating of Buy, Bank of America initiated coverage on Horizon Therapeutics PLC (NASDAQ: HZNP). The price target is set at $34.00 for Horizon Therapeutics. In the second quarter, Horizon Therapeutics showed an EPS of $0.49, compared to $0.48 from the year-ago quarter. The total market value of Horizon Therapeutics's outstanding shares is at $5.1 billion. The stock has a 52-week-high of $29.44 and a 52-week-low of $16.56. Horizon Therapeutics's stock last closed at $27.19 per share.
  • Oppenheimer initiated coverage on Interpace Diagnostics Group Inc (NASDAQ: IDXG) with an Outperform rating. The price target for Interpace Diagnostics Gr is set at $3.00. Interpace Diagnostics Gr earned ($0.10) in the second quarter, compared to ($0.07) in the year-ago quarter. The current market cap for Interpace Diagnostics Gr is at $28.8 million. The stock has a 52-week-high of $1.74 and a 52-week-low of $0.67. Interpace Diagnostics Gr's stock last closed at $0.77 per share.
  • Barclays initiated coverage on Nabors Industries Ltd (NYSE: NBR) with an Overweight rating. The price target for Nabors Industries is set at $3.50. For the second quarter, Nabors Industries had an EPS of ($0.41), compared to year-ago quarter EPS of ($0.39). Nabors Industries's market cap stands at $788.7 million. The stock has a 52-week-high of $6.65 and a 52-week-low of $1.60. Nabors Industries's stock last closed at $2.08 per share.
  • With a rating of Speculative Buy, Benchmark initiated coverage on Orgenesis Inc (NASDAQ: ORGS). The price target is set at $9.00 for Orgenesis. The current market cap for Orgenesis is at $69.7 million. The stock has a 52-week-high of $9.25 and a 52-week-low of $3.78. Orgenesis's stock last closed at $4.20 per share.
  • With a rating of Equal-Weight, Barclays initiated coverage on Patterson-UTI Energy Inc (NASDAQ: PTEN). The price target is set at $10.00 for Patterson-UTI Energy. In the second quarter, Patterson-UTI Energy showed an EPS of ($0.17), compared to ($0.06) from the year-ago quarter. The total market value of Patterson-UTI Energy's outstanding shares is at $1.8 billion. The stock has a 52-week-high of $18.24 and a 52-week-low of $7.87. Patterson-UTI Energy's stock last closed at $9.10 per share.
  • For Rocket Pharmaceuticals Inc (NASDAQ: RCKT), Piper Jaffray initiated coverage, by setting the current rating at Overweight. In the second quarter, Rocket Pharmaceuticals showed an EPS of ($0.38), compared to ($0.40) from the year-ago quarter. Rocket Pharmaceuticals's market cap stands at $637.1 million. The stock has a 52-week-high of $25.86 and a 52-week-low of $10.75. Rocket Pharmaceuticals's stock last closed at $12.55 per share.

Posted-In: Initiations top upgradesUpgrades Downgrades Initiation Intraday Update Analyst Ratings

 

Related Articles (AAN + ABBV)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
ESYJYBarclaysUpgrades
BCOGoldman SachsInitiates Coverage On108.0
KSSGoldman SachsDowngrades48.0
TWGoldman SachsUpgrades53.0
IRaymond JamesUpgrades12.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Thursday's Market Minute: CEO Exodus

Tobacco Company Imperial Brands, Auxly Cannabis Close On Partnership, $92.8M Investment